Table 1.
Primer | Sequence | Product size (bp) |
---|---|---|
Primers for genotyping | ||
Tfr1 loxP | F: 5′-CAG TAA CAG AGG AAT CAT TAG-3′ | WT 500 and floxed 650 |
R: 5′-CTA AAC CGG GTG TAT GAC AAT G-3′ | ||
HSA-Cre | F: 5′-GCC TGC ATT ACC GGT CGA TGC AAC GA-3′ | 750 |
R: 5′-GTG GCA GAT GGC GCG GCA ACA CCA TT-3′ | ||
HSA-rtTA | F: 5′-ACT GAG AGG TGG GAA GCT CA-3′ | 284 |
R: 5′-GGC GAG TTT ACG GGT TGT TA-3′ | ||
HSA-rtTA,tetO-Cre | F: 5′-AGG TGT AGA GAA GGC ACT TA-3′ | 412 |
R: 5′-CTA ATC GCC ATC TTC CAG CA -3′ | ||
Primers for RT-PCR | ||
Transferrin | F: 5′-TGG GGG TTG GGT GTA CGA T-3′ | 103 |
R: 5′-AGC GTA GTA GTA GGT CTG TGG-3′ | ||
Tfr1 | F: 5′-GTT TCT GCC AGC CCC TTA TTA T-3′ | 152 |
R: 5′-GCA AGG AAA GGA TAT GCA GCA-3′ | ||
Tfr2 | F: 5′-TTG GGG TCT ACT TCG GAG AGT-3′ | 179 |
R: 5′-GAC AGG AGC CTA AGT GCT CAG-3′ | ||
Myod1 | F: 5′-CCA CTC CGG GAC ATA GAC TTG-3′ | 109 |
R: 5′-AAA AGC GCA GGT CTG GTG AG-3′ | ||
Myogenin | F: 5′-GAG ACA TCC CCC TAT TTC TAC CA-3′ | 106 |
R: 5′-GCT CAG TCC GCT CAT AGC C-3′ | ||
Mef2c | F: 5′-ATC CCG ATG CAG ACG ATT CAG-3′ | 110 |
R: 5′-AAC AGC ACA CAA TCT TTG CCT-3′ | ||
MCK | F: 5′-CTG ACC CCT GAC CTC TAC AAT-3′ | 193 |
R: 5′-CAT GGC GGT CCT GGA TGAT-3′ | ||
Foxo1 | F: 5′-CCC AGG CCG GAG TTT AAC C-3′ | 132 |
R: 5′-GTT GCT CAT AAA GTC GGT GC-3′ | ||
Actb | F: 5′-GGC TGT ATT CCC CTC CAT CG-3′ | 154 |
R: 5′-CCA GTT GGT AAC AAT GCC ATG T-3′ |
Actb: Beta-actin; F: forward; Foxo1: forkhead box protein O1; HSA: skeletal muscle actin; MCK: muscle creatine kinase; Mef2C: myocyte enhancer factor 2C; R: reverse; RT-PCR: reverse transcription-polymerase chain reaction; Tfr: transferrin receptor; WT: wild type.